Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study

被引：0
|
作者：
Shanmuganathan, J. [1 ]
Schou, M. S. Morten [2 ]
Butt, J. H. B. Jawad Haider [3 ]
Torp-Pedersen, C. T. P. Christian [3 ]
Poulsen, L. O. P. Laurids Ostergaard [1 ]
Pareek, M. P. Manan [3 ]
Gislason, G. G. Gunnar [3 ]
Kober, L. K. Lars [3 ]
Nielsen, D. N. Dorte [2 ]
El-Galaly, T. C. E. Tarec Christoffer [1 ]
Soegaard, P. S. Peter [1 ]
Mamas, M. A. M. Mamas A. [4 ]
Freeman, P. F. Phillip [1 ]
Kragholm, K. H. K. Kristian Hay [1 ]
机构：
[1] Aalborg Univ Hosp, Aalborg, Denmark
[2] Herlev Hosp, Dept Cardiol, Herlev, Denmark
[3] Copenhagen Univ Hosp, Dept Cardiol, Rigshosp, Copenhagen, Denmark
[4] Keele Univ, Cardiol, Keele, Staffs, England
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Vascular Endothelial Growth Factor Inhibitor Therapy and Cardiovascular and Renal Damage in Renal Cell Carcinoma
    Lai, Silvia
    Molfino, Alessio
    Seminara, Patrizia
    Longo, Flavia
    Innico, Georgie
    Coppola, Bettina
    Mastroluca, Daniela
    Galani, Alessandro
    Dimko, Mira
    Aceto, Paola
    Lai, Carlo
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (02) : 190 - 196
  • [2] TUMOUR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS (VEGFR) POLYMORPHISMS AND CLINICAL OUTCOME IN ADVANCED RENAL CELL CARCINOMA PATIENTS RECEIVING FIRST LINE SUNITINIB
    Bianconi, M.
    Scartozzi, M.
    Faloppi, L.
    Loretelli, C.
    Burattini, L.
    Bittoni, A.
    Del Prete, M.
    Giampieri, R.
    Montironi, R.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 274 - 274
  • [3] Risk of post-injection endophthalmitis peaks within the first three injections of anti-vascular endothelial growth factor therapy: A nationwide registry-based study
    Thinggaard, Benjamin Sommer
    Pedersen, Frederik
    Kawasaki, Ryo
    Wied, Jimmi
    Subhi, Yousif
    Grauslund, Jakob
    Stokholm, Lonny
    ACTA OPHTHALMOLOGICA, 2024, 102 (08) : 953 - 962
  • [4] Risk of pacemaker implantation after femur fracture in patients with and without a history syncope: a Danish nationwide registry-based follow-up study
    Clemmensen, Sara L. K.
    Kragholm, Kristian
    Tayal, Bhupendar
    Torp-Pedersen, Christian
    Kold, Soren
    Sogaard, Peter
    Riahi, Sam
    JOURNAL OF GERIATRIC CARDIOLOGY, 2022, 19 (09) : 712 - 718
  • [5] Risk of pacemaker implantation after femur fracture in patients with and without a history syncope: a Danish nationwide registry-based follow-up study
    Sara LK Clemmensen
    Kristian Kragholm
    Bhupendar Tayal
    Christian Torp-Pedersen
    S?ren Kold
    Peter S?gaard
    Sam Riahi
    Journal of Geriatric Cardiology, 2022, 19 (09) : 712 - 718
  • [6] Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration
    Scott, Adrienne W.
    Bressler, Susan B.
    CURRENT OPINION IN OPHTHALMOLOGY, 2013, 24 (03) : 190 - 196
  • [7] Major adverse cardiovascular events following electroconvulsive therapy in depression: A register-based nationwide Swedish cohort study with 1-year follow-up
    Nordenskjold, Axel
    Guney, Pelin
    Nordenskjold, Anna M.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 296 : 298 - 304
  • [8] Conditional survival in patients treated with vascular endothelial growth factor-targeted therapy for advanced renal cell carcinoma
    Zhu, Y.
    Hong, Y. P.
    Zhang, H. L.
    Shi, G. H.
    Xiao, W. J.
    Wang, Z. H.
    Yao, X. D.
    Zhang, S. L.
    Dai, B.
    Ye, D. W.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (11) : 1901 - 1907
  • [9] Conditional survival in patients treated with vascular endothelial growth factor-targeted therapy for advanced renal cell carcinoma
    Y. Zhu
    Y. P. Hong
    H. L. Zhang
    G. H. Shi
    W. J. Xiao
    Z. H. Wang
    X. D. Yao
    S. L. Zhang
    B. Dai
    D. W. Ye
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 1901 - 1907
  • [10] CASSIOPE: A prospective noninterventional study of cabozantinib treatment following prior vascular endothelial growth factor (VEGF) -targeted therapy in patients with advanced renal cell carcinoma (aRCC).
    Staehler, Michael D.
    Bigot, Pierre
    Barthelemy, Philippe
    Hamberg, Paul
    Suarez, Cristina
    Eymard, Jean-Christophe
    Gajate, Pablo
    Perrot, Valerie
    Qvick, Bryan
    Dutailly, Pascale
    Procopio, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345